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Sepsis induces long-term metabolic and
mitochondrial muscle stem cell dysfunction
amenable by mesenchymal stem cell therapy
P. Rocheteau1,*, L. Chatre2,3,*, D. Briand1, M. Mebarki1, G. Jouvion1, J. Bardon1, C. Crochemore2,3, P. Serrani1,
P.P. Lecci1, M. Latil1, B. Matot4,5, P.G. Carlier4,5, N. Latronico6, C. Huchet7, A. Lafoux7, T. Sharshar1,8,9,10,
M. Ricchetti2,3 & F. Chre´tien1,10,11,12
Sepsis, or systemic inﬂammatory response syndrome, is the major cause of critical illness
resulting in admission to intensive care units. Sepsis is caused by severe infection and is
associated with mortality in 60% of cases. Morbidity due to sepsis is complicated by
neuromyopathy, and patients face long-term disability due to muscle weakness,
energetic dysfunction, proteolysis and muscle wasting. These processes are triggered by
pro-inﬂammatory cytokines and metabolic imbalances and are aggravated by malnutrition
and drugs. Skeletal muscle regeneration depends on stem (satellite) cells. Herein we
show that mitochondrial and metabolic alterations underlie the sepsis-induced long-term
impairment of satellite cells and lead to inefﬁcient muscle regeneration. Engrafting
mesenchymal stem cells improves the septic status by decreasing cytokine levels, restoring
mitochondrial and metabolic function in satellite cells, and improving muscle strength. These
ﬁndings indicate that sepsis affects quiescent muscle stem cells and that mesenchymal stem
cells might act as a preventive therapeutic approach for sepsis-related morbidity.
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S
epsis is deﬁned as an infection that causes an uncontrolled
systemic inﬂammatory response that leads to vascular
leakage, tissue damage and multiorgan failure. In many
cases, sepsis results in swift death, and current treatments are not
very effective1. Patients who survive frequently suffer from
muscle wasting2–4. In the early phases of sepsis, catabolism of
skeletal muscle can be beneﬁcial because it provides glutamine to
gut mucosa5 and to the immune system6, and supports
gluconeogenesis and acute phase protein synthesis in the liver
by providing amino acids7. However, if this catabolic activity
persists, it provokes muscle loss and becomes detrimental8. This
is especially true when respiratory muscles are targeted9. Indeed,
continued loss of muscle proteins, particularly myoﬁbrillar
proteins10,11, results in muscle atrophy and weakness, which
have signiﬁcant clinical consequences. In survivors of critical
illness, this physical disability can last for 5 years12,13.
Normally, skeletal muscle is capable of remarkable regenera-
tion in response to injury or trauma, a property conferred by the
presence of muscle stem cells, satellite cells (SCs)14–16. Although
it is known that after sepsis the imbalance between anabolism and
catabolism leads to muscle wasting, the mechanisms that cause
the failure of muscle regeneration after extended periods of time
are still not clear. To address this issue, we focus on muscle
regeneration and SC function following septic shock. We show
long-lasting mitochondrial and metabolic alterations in SC after
sepsis, which are associated with inefﬁcient muscle regeneration.
We also show that these alterations, as well as high cytokine
levels, are reverted by engrafting mesenchymal stem cells,
resulting in improved septic state and increased muscle
strength. These ﬁndings reveal that quiescent muscle stem cells
are affected by sepsis and that mesenchymal stem cells may have
use in preventive therapeutic approaches.
Results
Muscle is not able to regenerate after sepsis. Sepsis was induced
in mice by caecal ligature and puncture (CLP), which generates an
exacerbated immune response and simulates clinically relevant
human conditions17. Twenty-four hours post CLP, we observed
severe but transitory hypoxia in the tibialis anterior (TA)
muscle of septic mice (Fig. 1a–e), despite normal histology
(Supplementary Fig. 1a–m). The hypoxic condition could not be
ascribed only to reduced perfusion. Indeed, functional magnetic
nuclear resonance (MNR) analysis revealed large variability in the
response to perfusion after sepsis (11ml per min per 100 g±12,
mean±s.d., see Supplementary Table 1), whereas hypoxia was
similar in all septic mice. The muscle regenerative capacity of septic
mice was assessed after injury of the TA muscle with notexin at
the time of CLP. We note that, unlike control mice, muscle
regeneration was compromised in septic mice as revealed by: (i)
marked anisocytosis and a high proportion of small atrophic
myoﬁbers (21 days after injury, ﬁbre size 123±35mm2 post injury
versus 45±40mm2 post injury and sepsis; and 104±64 ﬁbres per
mm2 post injury versus of 35±24 ﬁbres per mm2 post injury and
sepsis); (ii) endomysial ﬁbrosis, representing 64±11% of the total
muscle section surface area; (iii) persistence of chronic endomysial
inﬂammation; and (iv) calciﬁcation of necrotic myoﬁbers
accompanied by multinucleated giant cells (Fig. 1f–j). To support
these histological observations, we assessed the levels of creatine
kinase, a marker of necrosis. Twenty-one days post injury, creatine
kinase returned close to basal levels in the injured control mice,
whereas it remained high in the septic mice (Supplementary
Fig. 1n). These effects persisted at later time points, and
regeneration was defective whether injury was performed at the
same time or 4 days to 3 months post CLP (Supplementary
Fig. 2a–g).
Satellite cells are impaired after sepsis. We then focused on SCs,
which play a central role in muscle homeostasis and regenera-
tion14–16. Using Tg:Pax7nGFP transgenic mice to isolate SCs by
ﬂuorescence-activated cell sorting (FACS)18, we observed a
marked decrease (89%) in SC number 36 h post injury (Fig. 1k)
due to apoptosis (76±9% TUNEL-positive SCs, Fig. 1l, and
73±11% cleaved caspase-3 SC, Supplementary Fig. 2h–j). These
data were conﬁrmed using Pax7LacZ/þmice, which displayed loss
of 80% of SCs after sepsis and injury (Supplementary Fig. 2k,l). Of
the SCs surviving sepsis, 24.8±9.4% were actively cycling 3 days
post injury compared with 77.8±9.3% in controls (Fig. 1m–o).
The long-term division potential of SCs was also affected:
only 35.5±11% of cells were actively cycling over 3 days
(Supplementary Fig. 2m–o). These data were further conﬁrmed
by culturing SCs in vitro from control and septic Tg:Pax7nGFP
mice in normal as well as in septic mouse serum (Fig. 2a–g). The
septic serum was extracted from the blood of septic mice 24 h
post CLP, and healthy serum was obtained from non-treated
mouse blood. SC division was impaired when cultured in a septic
environment or when originating from septic mice suggesting
that not only extrinsic (Fig. 2b,d,g) but also intrinsic factors
(Fig. 2b,e,g) affected SC division after sepsis. Moreover, except for
controls in normal serum, SCs were unable to differentiate into
myoﬁbers in all other conditions (Fig. 2d–f). SC velocity also
markedly decreased, as measured by live video microscopy
(Fig. 2h–l and Supplementary Movies 1–4). The expression of
MyoD, one of the earliest myogenic commitment markers19,20,
was impaired in the septic condition. Indeed, after 24 h, 91±7%
of SCs expressed MyoD in injured mice versus 34±5% of SCs
surviving injury and sepsis (Supplementary Fig. 2p). These results
were conﬁrmed 4 days after the induction of sepsis and injury.
The myogenic factor myogenin (MyoG), a marker of
differentiation21, was also expressed at lower levels in septic
conditions than in controls. In vivo, 8-fold and 49-fold fewer SCs
expressed MyoG in septic mice 4 days and 7 days, respectively,
post injury and sepsis compared with non-septic injured mice
(Supplementary Fig. 2q). These results were conﬁrmed in vitro.
Indeed, 4 days post plating, 4±1.7% of FACS-sorted SCs in septic
serum were positive for MyoG versus 27±7.5% of SCs in non-
septic serum. At 7 days post plating, 8±1.5% of the few surviving
SCs were MyoG positive in septic serum versus 70±4% in
controls (Supplementary Fig. 2r).
In agreement with our in vivo observations, these data show
that only 11% of SCs resist sepsis; most of these cells have
compromised activation and proliferation as well as impaired
expression of myogenic markers.
Altered mitochondrial activity in impaired SCs after sepsis.
Analysis of muscle bioenergetics, assessed by 31P-NMR spectro-
scopy, revealed signiﬁcant metabolic impairments during the
early stages of sepsis (lower muscle pH and PCr/ATPg, reﬂecting
abnormal energy metabolism in septic muscle tissue compared
with controls; Supplementary Table 1). To better understand the
functional effects of sepsis on SCs and the pathophysiologic
mechanisms behind alterations in muscle metabolism,
we assessed mitochondrial parameters in SCs during sepsis.
We observed transitory stimulation of the expression of
hypoxia-inducible factor-1 alpha (Hif1a)22 from 24 to 48 h post
sepsis (Fig. 3a), in accordance with the hypoxia observed in the
TA muscle at 24 h (see above, Fig. 1b). Hif1a is induced by
reactive oxygen species (ROS)23, and accordingly, we observed
ROS levels peaking at 24 h post sepsis (Supplementary Fig. 3a).
Six hours after induction of sepsis, NADPH oxidase 1 (Nox1)24
and antioxidant defence factors, speciﬁcally cytosolic Sod1
and mitochondrial Sod2 superoxide dismutase factors25, were
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Figure 1 | Muscle regeneration is impaired during sepsis. (a) Schematic representation of sacriﬁce post CLP and injury. (b) Intensity of ﬂuorescence
measured by microscopy and quantiﬁed using ImageJ of hypoxyprobe at different time points post CLP. (c–e) Hypoxyprobe immunostaining of
cryosectioned TA muscle at 6, 24 and 48 h post induction of sepsis, respectively. Scale bar, 200mm. Haematoxylin and eosin staining of a TA 21 days (d)
post injury (f) and 21 days post injury and CLP (g) in 8-week-old mice. Scale bar, 100mm. Sirius Red staining of TA muscle 21 days post injury (h) or 21 days
post sepsis and injury (i). Scale bar, 100mm. (j) Percentage of ﬁbrotic area measured using the threshold method with ImageJ in septic injured mice versus
healthy injured mice. (k) Absolute number of satellite cells (counted by FACS) isolated 36 h post injury in the TA muscle of septic (CLP) Tg:Pax7nGFP
transgenic mice (n¼ 5). (l) Percentage of TUNEL-positive cells 36 h post CLP and injury, n¼ 5 TgPax7nGFP mice killed and satellite cells FACS cell sorted
per condition. (m–o) Percentage of cycling SC at different time points post injury and sepsis. (m) Percentage of EdU-positive SC in injured (controls), and
injured and septic animals at different time points post injury. (n) Representative image of double Pax7/EdU staining 3 days post injury (regeneration in
control mice). (o) Representative picture of double Pax7/EdU staining 3 days post injury and sepsis (arrows point single-labelled satellite cells, that is,
non-cycling SC). On the right (lower magniﬁcation) individual staining is shown. For all time points mice were between 8 and 12 weeks old, and n¼8
animals were analysed. Data are represented as mean±s.d. *Po0.05; **Po0.01 (Mann–Whitney test). NS, not signiﬁcant.
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upregulated in SCs (Fig. 3b–d), suggesting an active response to
oxidative stress. Superoxide dismutase (SOD) activity increased
with time post sepsis, even with low RNA levels (Supplementary
Fig. 3b). Consistent with a strong antioxidant defence, we
observed a rapid decrease in carbonylated and nitrated protein
levels26 in SCs (Fig. 3f,g) that persisted for 21 days post sepsis
(this was also the case for ROS, Supplementary Fig. 3a), indicating
reduced nitroso-redox stress17. The reduction in protein nitration
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Figure 2 | Muscle satellite cell division is impaired in the presence of septic serum. (a) Schematic representation of the experimental approach for the
in vitro test of septic conditions. (b–f) Percentage of cycling cells in different septic conditions in vitro. (b) Percentage of EdUþ myoblasts (cycling satellite
cells) cultured in regular conditions (control healthy Tg:Pax7nGFPmice, control serum) or extracted from septic Tg:Pax7nGFP in normal serum (septic animal
in control serum) or extracted from healthy Tg:Pax7nGFP in septic serum (control animal in septic serum) or extracted from septic Tg:Pax7nGFP in septic
serum. (c–f) Representative picture of FACS cell-sorted satellite cells from Tg:Pax7nGFPmice and plated in the different conditions described above, labelled
with EdU and ﬁxed/labelled 3 days post plating. (c) Non-septic Tg:Pax7nGFP in non-septic mouse serum. (d) Healthy Tg:Pax7nGFP in septic serum.
(e) Septic Tg:Pax7nGFP in non-septic serum. (f) Septic Tg:Pax7nGFP in septic serum. (g) Cells from healthy (non-septic) and septic Tg:Pax7nGFP mice were
FACS cell sorted and plated at 100 cells per well density. Clonal analysis of the proliferation through time (from T0 to 7 days post plating) was performed
using Opera system (automatic clonal cell count). (h–l) Live video microscopy of all conditions previously mentioned (see a). (h) Control (that is, healthy
cells in non-septic mouse serum), (i) healthy cells in septic serum, (j) septic cells in non-septic serum and (k) septic cells in septic serum. (l) Velocity of
cells measured in mmh 1 in all four conditions. Tg:Pax7nGFP mice were between 8 and 12 weeks old, n¼4. Data are represented as mean±s.d. *Po0.05;
**Po0.01; ***Po0.001; ****Po0.0001 (Mann–Whitney test). GFP, green ﬂuorescent protein; NS, not signiﬁcant.
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was speciﬁc to satellite cells because myoﬁbers displayed
increased protein nitration 24 h post sepsis (Supplementary
Fig. 3c,d,g). Conversely, protein carbonylation was reduced in
SCs as well as in myoﬁbers (Supplementary Fig. 3e,f,h). Strikingly,
the expression of Pgc1a, a master regulator of ROS detoxiﬁcation,
gluconeogenesis, mitochondrial biogenesis, metabolism and
muscle wasting27, markedly and persistently decreased in SCs
after sepsis (Fig. 3e). Accordingly, we observed a remarkable and
persistent reduction of the mitochondrial mass (Z70%),
measured with MitoTracker Deep red and by assessing
mitochondrial translocase TOM22 immunoﬂuorescence
(Fig. 3h,i)28,29. The decrease in mitochondrial mass was speciﬁc
to SCs because after sepsis the mitochondria of myoﬁbers
displayed increased MitoTracker Deep Red and TOM22 signals
(Supplementary Fig. 4a–e).
Mitochondrial activity strongly depends on mitochondrial
DNA (mtDNA). SCs lost 40% of their mtDNA by 24 h post sepsis
(Fig. 3j). Intriguingly, the reduction in mtDNA was uncoupled to
the initiation of mtDNA replication. Global mitochondrial
transcript content (mTRANS probe) and initiation of mtDNA
replication (mREP probe) were assessed in situ and at single-cell
resolution28 (Supplementary Fig. 5a,b), and transcripts of
mitochondrial genes CytB and 16S rRNA were assessed by
real-time quantitative PCR (RT–qPCR) (Supplementary
Fig. 5c,d)28,29. Moreover, we detected a marked accumulation
of mtDNA size alterations from 6 h to 4 days post sepsis (with
alterations located in an E6-kbp region of the mtDNA),
supporting the notion of persistent mitochondrial dysfunction
after sepsis (Fig. 3k). At 24 h post sepsis, residual mitochondria
were hyperpolarized (Fig. 3l). In addition, although quiescence
favours glycolysis30, we detected a slight increase of oxidative
phosphorylation (OXPHOS) in SCs during sepsis, despite an
overall decrease in ATP levels (Fig. 3m,n), reﬂecting the
hyperactivity of mitochondria surviving sepsis in SCs, but no
increase in O2 consumption rate (Fig. 3o). Bioenergetics analysis
performed with Seahorse technology revealed that the rates of
maximal respiration, proton leak, spare respiratory capacity and
coupling efﬁciency were comparable in septic SCs and controls
(Supplementary Fig. 4f–l). Altogether, sepsis had rapid, strong
and persistent effects on mitochondrial mass, mtDNA content
and mtDNA integrity. Nevertheless, despite an unfavourable
environment, residual mitochondria appeared hyper-replicative,
hyper-transcription active and hyperpolarized, leading to a
metabolic shift towards OXPHOS. This altered mitochondrial
activity and metabolic unbalance could explain the impaired
ability of SCs to regenerate muscle.
Mesenchymal stem cells restore mitochondrial function.
Exogenous administration of puriﬁed mesenchymal stem cells
(MSCs) has been shown to have a protective effect against sepsis
in different organs31–34. To investigate if MSCs had a protective
effect on satellite cells, we sorted MSCs from non-septic C57Bl/6
bone marrow by FACS (CD45 , Ter119 , PDGFR1aþ and
Sca1þ )35 and injected 300,000 cells intramuscularly in 15 ml of
0.9% NaCl, 6 h after induction of sepsis and injury (Fig. 4a).
Under these conditions and at that time, SCs were already
impaired (see above, Fig. 3a–h,k). Muscle regeneration, evaluated
histologically by examining newly formed myoﬁbers 21 days post
injury and sepsis, was more efﬁcient in the presence of MSCs
(104±64 ﬁbres per mm2) compared with untreated septic and
injured controls (35±24 ﬁbres per mm2, Pr0.001), with larger
ﬁbres (45±40 mm2 post injury and sepsis versus 112±69 mm2
post injury, sepsis and MSC treatment, Pr0.01; Fig. 4b–c).
Moreover, MSC-treated mice displayed less ﬁbrosis and necrosis
than controls (Fig. 4d–f and Supplementary Fig. 5e). The initial
drop in leukocytes after CLP36 was restored 3 days after MSC
injection (Supplementary Fig. 5f). The leukocyte count in the
blood indicated the absence of infection 21 days after induction of
sepsis (in survivors), either with or without injection of MSCs
(Supplementary Fig. 5g). Moreover, the level of procalcitonin, an
early indicator of sepsis, was closer to the level of the controls
when mice were injected with MSCs (Supplementary Fig. 5h). We
also observed a decrease in the levels of cytokines 24 h after
injection of MSCs, as exempliﬁed by interleukin-6 (Fig. 4g and
Supplementary Fig. 6a). Furthermore, we report lower levels of
cytokines in the septic TA injected with MSCs compared with the
contralateral, non-injected TA (Supplementary Fig. 5i). When
injured, non-injected TA muscles were unable to regenerate
properly (42±15 ﬁbres per mm2 (Supplementary Fig. 5j)).
On MSC injection, most mitochondrial parameters returned to
normal in FACS-sorted SCs: that is, mitochondrial membrane
potential (Fig. 4h), ATP levels (Fig. 4i), relative percentage of
glycolytic and mitochondrial ATP (Fig. 4j), expression of
mitochondrial biogenesis (Pcg1a) and antioxidant response
(Sod2) factors (Fig. 4k), mitochondrial mass (Fig. 4l) and mtDNA
content (Fig. 4m). Moreover, after injection of MSCs, the mtDNA
alterations observed in SCs 24 h post induction of sepsis
disappeared in favour of full-size mtDNA (Fig. 4n). Thus, fast
recovery of mitochondrial status in septic SCs was subsequent to
MSC treatment and linked to restored regeneration of muscle in
septic mice.
MSCs have been shown to differentiate into multiple lineages37,
including muscle38, depending on the surrounding environment39.
After injecting MSCs, isolated as previously described, into double-
transgenic Tg:CAG-hPLAP::MLC3F-nlacZ-2E septic injured mice
(mice carrying both the human placental alkaline phosphatase gene
that is expressed ubiquitously39 and LacZ that marks differentiated
myonuclei40), we did not detect any PLAP-positive ﬁbres, any
PLAP-positive SCs or X-gal staining (Supplementary Fig. 6b–d).
This indicates that the donor MSCs did not differentiate into
muscle or SCs. To investigate whether MSC injection and
subsequent improvement of muscle regeneration had functional
consequences, contractile protein properties and force production
were assessed using skinned ﬁbre experiments. In ﬁbres isolated
from septic and injured TA muscle, the tension signiﬁcantly
increased from pCa 6.25 to pCa 4.5 after MSC injection (Fig. 4o).
Thus, although the maximal Ca2þ -activated tension increased by
91.4±10.2% (n¼ 35 ﬁbres sampled), we did not observe
modiﬁcations in Ca2þ sensitivity or the Hill coefﬁcient
(Supplementary Fig. 6e,f), indicating a larger loss of contractile
proteins in non-injected versus MSC-treated TA, and suggesting
that the ﬁbre type composition did not change after MSC
treatment41,42. Furthermore, although injection was limited to
the TA, we evaluated the recovery of the entire limb. The grip test
performed 21 days after MSC injection, although globally
nonsigniﬁcant, revealed that several septic mice injected with
MSC displayed larger body force than non-injected mice
(Supplementary Fig. 6g). Altogether, these data demonstrate that
MSC treatment after sepsis induces more efﬁcient muscle
regeneration and has a functional impact by improving muscle
ﬁbre tension.
Discussion
Critical illness myopathy is a major complication of sepsis43,44,
which is one the main causes of admission and mortality in the
intensive care unit (ICU). Critical illness myopathy affects up to
4% of septic patients and is independently associated with
increased ICU and post-ICU mortality12,44, failure of weaning
from mechanical ventilation and long-term disability12.
The pathophysiology of critical illness myopathy is complex
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and multifactorial, involving mainly four mechanisms:
(1) impairment of membrane excitability related to ion channel
dysfunction; (2) energetics impairment related to mitochondrial
dysfunction; (3) proteolysis, mainly by activation of the
ubiquitins–proteasome complex; and (4) disturbance of
intracellular calcium homeostasis. These pathophysiological
processes then result in protein contractile dysfunction or loss,
thereby accounting for muscle weakness and wasting. Notably,
muscle wasting itself impairs and delays muscle recovery8. In
addition, critical illness myopathy can be associated with axonal
polyneuropathy that worsens and prolongs muscle dysfunction.
These mechanisms are triggered by various factors related to
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either sepsis or to ICU management, including circulating pro-
inﬂammatory cytokines, electrolyte and metabolic disturbances,
endocrine imbalance between anabolic and catabolic hormones,
myotoxic drugs (such as steroids) and unloading (that is, disuse).
Disuse is a major therapeutic target for reducing muscle weakness
and wasting. Indeed, various strategies are now recommended,
including early discontinuation of sedation, weaning from
mechanical ventilation and mobilization. Our ﬁndings might be
related to disuse at least to some extent because sepsis markedly
decreases mobility in the mice for the ﬁrst few days. However, this
disuse was not as intense and prolonged as that observed in septic
patients, and the mice moved normally 5 days post CLP.
Therefore, we think that disuse is unlikely to contribute to muscle
weakness in our animal model, and thus, we have assessed muscle
weakness but not muscle wasting in our model.
The muscle weakness, wasting and fatigue can persist for up to
5 years, with a marked impact on functional status and quality
of life. This outcome suggests an impairment of muscle
regeneration, which relies on SCs14–16. However, the hypothesis
of SC dysfunction in critical illness myopathy has not been
assessed to the best of our knowledge. In this study, we have
addressed this hypothesis using a validated model of critical
illness myopathy based on CLP and a validated model of injury15.
We identiﬁed a novel mechanism for critical illness myopathy,
that is, an early and long-lasting dysfunction of satellite cells that
durably impairs muscle regeneration, replacing a fully functional
muscle with a huge ﬁbrotic area. Indeed, as early as 6 h
post induction of sepsis, we observed a massive loss of
proliferating/activated SCs. The remaining SCs displayed
abnormal mitochondrial activity along with loss of
mitochondrial mass and degraded mtDNA, but they also
displayed hyper-replication-active, hyper-transcription-active
and hyperpolarized organelles leading to an increase of
OXPHOS. Although glycolysis remained prevalent, as for
quiescent cells that are characterized by low metabolism30,
septic SCs relied more extensively on mitochondria for ATP
production than controls, in spite of markedly altered organelles.
This impairment was recapitulated in vitro with the inability of
SCs to divide, differentiate and self-renew in an environment
containing serum from a septic mouse. Three months post
induction of sepsis, the muscle was essentially unable to
regenerate, which suggests a lasting impairment that resembles
the impairment observed in the clinic and in patients that suffer
from muscle force loss for up to 5 years post sepsis45,46.
We showed that the functionality of SCs was restored by
mesenchymal stem cell injection47–51, leading to more efﬁcient
muscle regeneration, even when the treatment was performed
during sepsis. Although the systemic decrease of cytokines is
probably a part of the global mechanism leading to better
regeneration of muscle during sepsis, our data do not exclude a
more direct cell-to-cell rescue mechanism. The inability of the
contralateral (non-injected) TA muscle to regenerate when the
other TA muscle was treated with MSC suggests that local or
direct MSC contact with SCs is required for rescue. The
mitochondrial impairment in satellite cells occurs as early as 6 h
post induction of sepsis, and MSC injection during this critical
time promotes a rapid rescue of all mitochondrial and metabolic
parameters. The rapidity of mitochondrial, and thereby cellular,
impairment post sepsis as well as the recovery after MSC
treatment suggests that critical parameters linked to the long-
term effects are altered and can be rescued shortly after induction
of sepsis. In this context, mitochondrial and metabolic parameters
may act as read-outs of the status of critical cells during sepsis
and recovery.
These ﬁndings are clinically relevant as sepsis is the major
cause of critical illness myopathy, and administration of
mesenchymal stem cells is a therapeutic approach currently
tested in various acute diseases. Our ﬁndings provide evidence
that stem cells are deeply affected by sepsis, but for this
phenotype to emerge, SCs must be activated. In patients, such
activation could occur years after sepsis, on stimulation of
long-lasting quiescent SCs. The impaired regenerative potential of
activated SCs can thereby explain, at least in part, long-term
effects, notably muscle weakness, observed from several months
up to 5 years after sepsis.
Methods
Mouse experiments. We used a peritonitis induced by CLP as a model of sepsis
in mice C57Bl/6RJ from Charles River Laboratories or in-house transgenic
Tg:Pax7nGFP16. For isolation of MSC we used either in-house transgenic
Tg:CAG-hPLAP::MLC3F-nlacZ-2 or C57Bl/6Rj mice from Charles River. All mice
used in the study were male between 6 and 12 weeks old. Animals were
anaesthetized with ketamine (Imalgene1000, 100mg kg 1; Merial) and Xylazine
(Rompun 2%, 20mg kg 1; Bayer) before surgery. After laparotomy, caecum was
ligatured at the distal third with a 4.0 suture and the distal part was perforated
twice with a 21-Gauge needle. Animals were hydrated and treated with analgesic
(buprenorphine, Axience, 0.3mg kg 1) twice a day for 4 days following surgery.
For injury mice were anaesthetized as previously described and 10 ml of
12.5 mgml 1 notexin (Latoxan) was injected in the TA. All protocols were
reviewed by the Institut Pasteur, the competent authority, for compliance with the
Figure 3 | On sepsis satellite cells display altered but hyperactive mitochondria. (a–e) Quantiﬁcation by RT–qPCR of nuclear genes in the time course of
sepsis in the control (no injury no CLP) at 6 h, 24 h, 48 h and 4 days (d) post induction of sepsis; n¼6 per time point; (a) expression of hypoxia-inducible
factor1 (Hif1a); (b) NADPH oxidase 1 (Nox1); (c,d) expression of antioxidant enzymes Sod1 and Sod2; (e) peroxisome proliferator-activated receptor
coactivator 1 (PGC1a). (f,g) Quantiﬁcation of immunoﬂuorescence intensity by confocal microscopy image acquisition and ImageJ analysis. The levels
of carbonylated (antibody anti-dinitrophenyl) and nitrated (antibody anti-nitrotyrosine) proteins (resulting essentially from reactive oxidative and
nitrosative species, respectively) were measured in controls, 6 h, 24 h, 48 h and 4 days post induction of sepsis. Representative immunostaining
(three-dimensional-reconstructed cells) are displayed. Scale bar, 5 mm. (h) Confocal microscopy immunoﬂuorescence intensity quantiﬁcation of TOM22
(mitochondrial outer membrane protein) and (i) confocal microscopy intensity of MitoTracker Deep Red staining probe in control (healthy) and septic
mice. Once acquired by confocal microscopy the images were analysed using the mean grey value ImageJ plugin. (j) Mitochondrial DNA content (mtDNA)
in control and septic SC. (k) Agarose gel electrophoresis of long PCR ampliﬁcations on sorted SC mtDNA in controls and septic Tg:Pax7nGFP 6 h, 24 h, 48 h
and 4 days post sepsis showing mtDNA size alterations. Left panel, ampliﬁcation of a fragment of expected size (9,898 bp) from positions 7,998–16,299/1
(conventional end/origin of circular mtDNA) and 1–14,400 of the mtDNA; the image on this panel is intentionally highly contrasted to underscore multiple
bands, and also the low intensity of the expected band (9,898bp) in sepsis samples compared with controls; centre panel, schematic representation of
genes and regulatory regions in the human mtDNA, with the coordinates of PCR-ampliﬁed regions; right panel, ampliﬁcation of a fragment of expected size
9,677 bp from positions 15,377 to 5,701 of the mtDNA. Note that size alterations in cells from septic mice are present in one (left panel) but not the other
PCR-ampliﬁed fragment. (l) Tetramethylrhodamine ethylamine (TMRE; mitochondrial membrane potential) levels. (m) Relative percentage of glycolytic and
mitochondrial (OXPHOS) ATP in controls (no injury no CLP) and 24 h post sepsis. (n) Percentage of ATP relative to control in controls (n¼6) and septic
Tg:Pax7nGFP at 24 h (n¼ 6). (o) Basal mitochondrial respiration of SC in non-septic (control) and 24 h post sepsis evaluated with Seahorse XFe96 analyser.
Unless speciﬁed data are represented as mean±s.d. *Po0.05; **Po0.01; ***Po0.001; ****Po0.0001; NS, not signiﬁcant, compared with the respective
control (Mann–Whitney test).
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms10145 ARTICLE
NATURE COMMUNICATIONS | 6:10145 | DOI: 10.1038/ncomms10145 | www.nature.com/naturecommunications 7
French and European regulations on Animal Welfare and with Public Health
Service recommendations. This project has been reviewed and approved
(# 2013-0044) by the Institut Pasteur ethic committee (C2EA 89—CETEA).
Thymidine analogue and hypoxyprobe injections. Cell proliferation was
assessed using the thymidine analogue EdU incorporation. Animals received
intraperitoneal injections of 5-ethynyl-2’-deoxyuridine (EdU Invitrogen#A10044)
at 30mg/kg 12 and 2 h before sacriﬁce. EdU was revealed using click-it
reaction kit.
Hypoxia was detected using hypoxyprobe. Pimonidazole was injected at
120mg/kg 90min before sacriﬁce and revealed using monoclonal mouse antibody
(Hypoxyprobe #HP1-1000) directed against pimonidazole and Goat Anti-Mouse
IgG (Hþ L) Cy3 (ImmunoJackson #115-166-146).
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Histological analysis. TA was carefully dissected and snap frozen in liquid-
nitrogen-cooled isopentane for 5min and stored at  80 C before cryosectioning
(10-mm sections). Sections were kept at room temperature overnight before
staining. Sections were then rehydrated in PBS for 10min and ﬁxed in 10%
formalin for 3min. The sections were then routinely stained with haematoxylin
and eosin or with Sirius Red.
Immunostaining. Immunostaining was performed on cryosections ﬁxed with 4%
paraformaldehyde (PFA; EMS#15710) in cold PBS, permeabilized with 0.5% Triton
X-100 for 20min at room temperature, washed and blocked with 10% BSA for
30min. Sections were incubated with primary antibodies overnight at 4 C and
with Alexa-conjugated secondary antibodies 1/250 and Hoechst for 45min
(Supplementary Table 2). Sections were then analysed using an automated axioscan
(Zeiss) or inverted Observer.Z1 Apotome (Zeiss). For apoptosis assessment
(TUNEL assay and cleaved caspase-3 immunostaining), cells were collected in 2%
serum, spun on poly-D-lysine (Sigma-Aldrich #P6407) and immediately ﬁxed with
4% PFA . For mitochondrial immunostaining, freshly isolated adult muscle satellite
cells were ﬁxed with 2% PFA and permeabilized with 0.5% Triton X-100. Cells were
incubated overnight in blocking buffer (BSA 5% in PBS) at 4 C. Primary antibody
was then added for 1 h at room temperature, followed by secondary conjugated
antibody and 10mgml 1 Hoechst 33342 for 1 h at room temperature
(Supplementary Table 2).
Muscle cell sorting and culture. Muscle dissection was done by removing all of
the limb muscle from the mice, in cold DMEM. Muscles were then chopped with
small scissors and put in a 50-ml Falcon tube with collagenase 0.1% and trypsin
0.1% at 37 C with gentle agitation. After 20min, the supernatant was collected in
2% serum placed on ice, and the collagenase/trypsin solution was added to con-
tinue the digestion. Once muscle was completely digested, the solution was ﬁltrated
using 40-mm cell strainers. Satellite cells were cultured in 1:1 DMEM Glutamax
(Gibco #41965-039):MCDB201 (Sigma #M6770) containing 20% serum FBS
(Biowest S1860). When was used septic serum from mice, the serum was collected
from 24 h post CLP septic mice serum extracted from blood sampled from the
heart, spun at 400g at 4 C. The supernatant was collected and the serum was
kept frozen and thawed when preparing the medium. Medium was ﬁltered using
0.22-mm ﬁlters. Cells were plated on Matrigel coating (BD Biosciences #354234)
and kept in an incubator (37 C, 5% CO2) at an initial concentration of 15,000 cells
per mm2. For some in vitro experiments, serum was extracted from septic animals
24 h post CLP by heart puncture followed by centrifugation at 500g for 15min. The
thus-obtained supernatant replaced FBS in the culture medium; the rest of the
medium was unchanged.
For satellite cell counting, only the TA muscle was dissected and digested as
described earlier, and the totality of the tube was analysed to assess the number of
satellite cells per muscle. FACS analyses were done using a FACSAria (Beckman).
Analyses and quantitation were performed using Summit v4.3 software from
DakoCytomation, and FloJo software. Cells were labelled with propidium iodide
10mgml 1 (Sigma-Aldrich #P4170) to exclude dead cells and displayed using the
phycoerythrin (red) channel on the FACS proﬁle.
Isolation and culture of mesenchymal stem cells. MSCs were collected, cultured
and characterized from C57BL/6J (6 to 8 weeks old) or Tg:CAG-hPLAP::
MLC3F-nlacZ-2E mice. Brieﬂy, in anaesthetized mice (injected intraperitoneally
with 100mg per kg body weight of ketamine and 5mg per kg body weight of
xylazine), femurs were ﬂushed to recover bone marrow. For mesenchymal stem
cells isolation, the cell suspension was ﬁltered before red blood cell lysis and
incubated with the following antibodies: allophycocyanin-conjugated PDGFR-a,
FITC-conjugated Sca-1, phycoerythrin-conjugated CD45 and Ter119. Appropriate
gates were constructed on a cell sorter to exclude dead cells and lineage
(CD45(þ )Ter-119(þ ))-positive cells. Cells were plated in tissue culture ﬂasks,
and cultured in 1ml of complete medium at a density of 25 106 cells per ml. Cells
were incubated in plates at 37 C with 5% CO2 in a humidiﬁed chamber. After 3 h,
the supernatant was removed and non-adherent cells that accumulate on the
surface of the dish were replaced by changing the medium. After an additional 8 h
of culture, the medium was replaced with 1.5ml of fresh complete medium.
Thereafter these steps were repeated every 8 h for up to 72 h from the initial
culture. After 2 weeks from the initiating culture, cells were washed in PBS and
lifted by incubation in 0.5ml of 0.25% trypsin/1mM ethylenediaminetetraacetic
acid (EDTA) for 2min at room temperature.
Live video microscopy. Cells isolated by FACS were plated overnight on a 24-well
glass bottom plate (P24G-0-10-F; MatTek) coated with Matrigel (BD Biosciences
#354234) and placed in an incubator in pre-equilibrated medium (1:1 DMEM
Glutamax:MCDB (Sigma-Aldrich), 20% fetal calf serum (FCS; Biowest S1860). The
plate was then incubated at 37 C, 5% CO2 (Zeiss, Pecon). A Zeiss Observer.Z1
connected with a LCI PlnN  10/0.8W phase II objective and AxioCam camera
piloted with AxioVision was used. Cells were ﬁlmed for up to 5 days, and images
were taken every 30min with bright-ﬁeld and phase ﬁlters and MozaiX 3X3 (Zeiss).
Raw data were transformed and presented as a video.
Image analysis. For image analysis (ﬁbrosis quantiﬁcation) the ImageJ 1.46r
software analysed 10 randomly taken photos per section and minimum 3 sections
per experimental group. We converted each picture in a binary image and then
collected the pixel values. For ﬁbre size, the sections were immunostained with
rabbit anti Laminin (Sigma-Aldrich #L9393) diluted at 1/200, overnight at 4 C.
Secondary Donkey anti-Rabbit Alexa-488 (DL488 JacksonImmuno #711486152)
was used at 1/200 for 45min at room temperature. The ﬁbre perimeter was
automatically evaluated using the Pixcavator software.
Luminex. Snap-frozen TA samples (n¼ 4 per condition) were thawed and lysed,
and supernatant was processed for Luminex multiple cytokine and chemokine
analysis (Bio-Plex ProTM Mouse Cytokine Standard 23-Plex, Group I; and
Standard 9-Plex, Group II). Normalization was done by sample weight of frozen
muscle. The study of inﬂammatory cytokines was conducted on control, septic
and septic mice injected with MSCs.
Mitochondrial DNA analysis. Total genomic DNA samples were subjected to
PCR ampliﬁcation with LA Taq DNA polymerase (Takara) to amplify two large
mtDNA fragments that together span the whole mtDNA genome. PCR products
were subjected to 0.8% agarose electrophoresis gel. Two sets of primers were used:
forward 50-GGAGCCTCAATATTTTTT-30 and reverse 50-AATGATGGCTACAA
CGAT-30 , to amplify the 9,898-bp fragment (coordinates 14,400–7,998 of the
16,299-bp-long Mus musculus mitochondrial genome NC_006914); and forward
50-GATGAACAGTCTACCCAC-30 and reverse 50-GGGAGTAGCTCCTTCTTC-
30 to amplify the 9,677-bp fragment (coordinates 5,701–15,377).
Mitochondrial Transcription and Replication Imaging Protocol. DNA
probes for the ﬂuorescence in situ hybridization protocol called Mitochondrial
Transcription and Replication Imaging Protocol (mTRIP)28 was designed for the
Figure 4 | Mesenchymal stem cells improve muscle regeneration by decreasing septic state and restoring affected mitochondrial parameters in
satellite cells. (a) Schematic representation of timing of sacriﬁce, post-caecal ligature puncture and injury (with notexin) plus MSCs grafting.
(b) Haematoxylin and eosin staining of the TA 21 days (d) post sepsis and injury (n¼ 16). Scale bar, 100mm. (c) Haematoxylin and eosin of TA 21 days post
sepsis and injury with injection 6 h post injury of mesenchymal stem cells (n¼ 16). Scale bar, 100mm. (d–f) Fractions of ﬁbrotic area. (d) Fibrotic area of the
muscle tissue after regeneration (21 days post injury) in control, septic and septic injected with MSC conditions. (e) Sirius Red staining of muscle tissue of
septic mice 21 days post injury (n¼ 16) Scale bar, 100mm. (f) Sirius Red staining of muscle tissue 21 days post injury of septic mice treated with MSC
injection (n¼ 16). Scale bar, 100mm. (g) Example of Luminex on interleukin-6 (IL-6) representing the level of protein expression in pg g 1 of muscle tissue.
Control are non-injured mice (n¼4), septic Tg:Pax7nGFP at 24 h (n¼4) and septic Tg:Pax7nGFP injected with MSCs (n¼4). (h) TMRE label in injured
(n¼ 3); injured, septic TgPax7nGFP (n¼ 3); and injured, septic, MSC-injected TgPax7nGFP (n¼ 3) at 24 h. (i) ATP content relative to control (n¼ 6), septic
TgPax7nGFP (n¼ 6) and septic TgPax7nGFP injected with MSCs (n¼6) at 24 h. (j) Relative glycolytic and mitochondrial ATP content in controls (no injury
no CLP), 24 h post sepsis, and septic Tg:Pax7nGFP injected with MSCs. (k) Quantiﬁcation by RT–qPCR of PGC1a, Nox1, Hif1a, Sod1 and Sod2 expression.
(l) Relative level of intensity of MitoTracker Deep Red in controls, septic Tg:Pax7nGFP and septic Tg:Pax7nGFP injected with MSCs at 24 h (n¼ 6).
(m) Quantiﬁcation of mtDNA in FACS cell-sorted satellite cells in injured, injured and septic, and injured, septic and MSC-injected Tg:Pax7nGFP mice.
(n) Agarose gel electrophoresis of long PCR ampliﬁcation of mtDNA in SCs from controls, septic and septic mice injected with MSCs showing mtDNA
alterations only in septic mice (left panel). The coordinates of the ampliﬁed fragments are shown in Fig. 3k. MSCs rescue normal mitochondrial genome
size after sepsis. (o) Maximal tension of muscle ﬁbres of septic and injured (n¼ 6) compared with septic, injured and MSC-injected C57Bl/6 mice (n¼ 7)
according to the Ca2þ concentration. Data are represented as mean±s.d. *Po0.05; **Po0.01; ***Po0.001; ****Po0.0001; not signiﬁcant, compared
with the respective control (Mann–Whitney test).
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mouse mitochondrial genome and ampliﬁed using total mice DNA and the
following sets of primers:
mREP (coordinates on the mouse mitochondrial DNA: 15655–15758),
103 bp: forward 50-ATATGACTATCCCCTTCCCC-30 ; reverse 50-AGTTTAA
TGGGCCCGGAGCG-30 . mTRANS: equal mix 1:1:1 of 3 DNA probes MT1, MT6
and MT11. MT1 (1–1,021), 1,020 bp: forward 50-GTTAATGTAGCTTAATAA-30 ;
reverse 50-TTCCAAGCACACTTTCCA-30. MT6 (7,021–7,998), 978 bp: forward
50-CCCATTCCAACTTGGTCT-30 ; reverse 50-AATGATGGCTACAACGAT-30.
MT11 (13,140–14,357), 1,218 bp: forward 50-GTCATCTCATATAATATT-30 ;
reverse 50-TCGACAAATGTGTGTTAC-30.
A unit of 1 mg of mREP and 1 mg of mTRANS mix were labelled by nick
translation of PCR products, and incorporated in Atto550-dUTP following the
manufacturer’s procedure (Atto550 NT Labeling Kit, Jena Bioscience). For mREP
or mTRANS staining, 40 ng of labelled probe were mixed with 400 ng of sonicated
salmon sperm DNA (Life Technologies) in a ﬁnal 25-ml volume of hybridization
buffer (50% formamide, 10% dextran sulfate, in 2 saline sodium citrate buffer
(SSC; pH 7.0). DNA was denatured at 80 C for 10min and then kept at 37 C
for 30min. Freshly isolated adult muscle stem cells were ﬁxed with 2% PFA,
permeabilized with 0.5% Triton X-100, incubated in 50% formamide/2 SSC
(pH 7.0) for 30min at room temperature and denatured in 70% formamide/2
SSC for 4min at 75 C. Hybridization was performed with 40 ng of probe for 16 h
at 37 C. Slides were washed in SSC, and DNA was stained with 10 mgml 1 of
Hoechst 33342.
Carbonylated and nitrated protein levels. Freshly isolated adult muscle
stem cells were ﬁxed in 2% PFA and permeabilized with 0.5% Triton X-100.
Carbonylated protein levels were measured with 0.01% (100 mgml 1)
dinitrophenyl derivatization in 2N HCl for 1 h at room temperature in the dark,
followed by an overnight blocking step (5% BSA in PBS) at 4 C. Polyclonal rabbit
anti-dinitrophenyl antibody was then added for 1 h and secondary anti-rabbit
antibody Alexa Fluor 555 Conjugate and with 10 mgml 1 Hoechst 33342 for 1 h.
Nitrated protein levels were measured by blocking permeabilized cells (5% BSA
in PBS) overnight at 4 C, followed by 1 h incubation with the primary anti-
nitrotyrosine antibody, and 1 h with the secondary anti-rabbit antibody Alexa
Fluor 555 Conjugate, and 10 mgml 1 Hoechst 33342.
Mitochondrial and ROS assays. Mitochondrial membrane potential was
measured over 1 h on live, freshly isolated adult muscle stem cells using 200 nM
tetramethylrhodamine ethylamine (Sigma-Aldrich). Cells were incubated for 1 h
with the MitoTracker Deep Red staining (FM 8778S from Cell Signaling), a dye
that stains mitochondria in live cells. ROS were measured by incubating CellRox
(Life Technologies #C10422) 30min at 37 C and analysed by FACS.
Preparation and immunostaining of single muscle ﬁbres. The extensor
digitorum longus muscles were dissected from tendon to tendon and treated for 1 h
with 0.1% collagenase (C-0130, Sigma) at 37 C. The muscles were then ﬂushed to
separate single ﬁbres. Fibres were then transferred one by one into a dish using
serum-coated Pasteur pipettes. Single ﬁbres were then put in 20% FCS (Invitrogen)
in DMEM (Invitrogen):MCDB201 (Sigma) (1:1) medium with penicillin and
streptomycin, and ﬁxed with 2% PFA in PBS at room temperature. When
indicated, isolated muscle ﬁbres were incubated for 1 h with MitoTracker Deep
Red and then ﬁxed in 2% PFA. Single ﬁbres were immunostained for protein
carbonylation, protein nitration and mitochondrial TOM22, following the
respective procedures indicated above; immunostaining was performed in a 100-ml
volume in 2-ml Eppendorf tubes. Confocal acquisitions were performed using a
spinning-disk Perkin-Elmer Ultraview RS Nipkow Disk, an inverted laser-scanning
confocal microscope Zeiss Axiovert 200M with an Apochromat  25 objective and
a Hamamatsu ORCA II ER camera (Imagopole, PFID, Institut Pasteur). Optical
slices were taken at 200-nm intervals along the z axis covering the whole depth of
the cell, at a 1.024/1.024 pixel resolution. Three-dimensional reconstruction was
achieved using the IMARIS software (Bitplane). Fluorescence quantiﬁcation per
surface area was done using a single-imaging frame collection and ImageJ 1.47-v
software (post-acquisition analysis).
SOD activity. SOD activity was measured with Superoxide Dismutase
Activity Colorimetric Assay kit (Abcam, ab65354), following the manufacturer’s
instructions. This measurement assesses SOD-dependent inhibition of superoxide
anion reduction. Tests were performed with 10 mg of proteins, quantiﬁed by
Bradford assay, from 50,000 cells, per sample.
ATP assay. ATP levels were measured for 10,000 freshly isolated adult muscle
stem cells using the CellTiter-Glo luminescent assay following the manufacturer’s
procedure (Promega). When indicated, 10 mM oligomycin (Sigma-Aldrich) was
added for 1 h to inhibit mitochondrial ATP synthesis and assess glycolysis
contribution.
Cellular bioenergetics. Cellular bioenergetics was analysed on a Seahorse
extracellular ﬂux analyser (XFe96) according to the manufacturer’s instructions.
Brieﬂy, freshly FACS-isolated SCs were seeded at a density of 200 103 cells per
well in a Seahorse XF96 plate and incubated for 3 h in 3%O2/5% CO2 at 37 C.
The seeding density and incubation conditions were based on initial assays that
optimized oxygen consumption rate (OCR) and were compatible with attachment
and survival of SCs (from control and sepsis mice). No OCR signal was indeed
detected if the assay was performed immediately after isolation or 1 h incubation in
20%O2/5% CO2 at 37 C, including in experiments performed in the presence of
the cell immobilizer BD Cell Tak coating (BD Biosciences). Moreover, 3-h recovery
in 3%O2/5% CO2 at 37 C optimized the OCR signal. Immediately before the assay,
cultured cells were washed twice in minimal assay media (Seahorse Biosciences,
37 C, pH 7.40) supplemented with 25mM glucose, 1mM sodium pyruvate and
2mM L-glutamine, then equilibrated for 1 h in a non-CO2 incubator. The basal rate
of OCR and extracellular-acidiﬁcation rate (ECAR), as well as OCR and ECAR in
the presence of, successively, olygomycin (1mM) that inhibits ATP synthase and
distinguishes the part of mitochondrial respiration coupled to ATP production
from that due to proton leak, FCCP (0.5 mM) that uncouples mitochondrial
OXPHOS and measures maximal respiration and spare respiration capacity or cell
ability to respond to increased energy demand, and antimycin A/rotenone (1 mM)
that shut down mitochondrial respiration and measures non-mitochondrial
respiration, were measured in n¼ 3 mice per condition for 4min (over a total of
24min) from the rate of decline in O2 partial pressure (OCR), and rate of change in
assay pH (ECAR).
Three-dimensional confocal imaging and quantiﬁcation. Confocal acquisitions
were performed using a spinning-disk Perkin-Elmer Ultraview RS Nipkow Disk,
an inverted laser-scanning confocal microscope Zeiss Axiovert 200M with an
Apochromat  100/1.4 oil objective and a Hamamatsu ORCA II ER camera
(Imagopole, PFID, Institut Pasteur). Optical slices were taken at 200-nm intervals
along the z axis covering the whole depth of the cell, at a 1.024/1.024 pixel
resolution. Three-dimensional reconstruction was achieved using the IMARIS
software (Bitplane). Fluorescence quantiﬁcation was done using a single-imaging
frame collection and ImageJ 1.47-v software (post-acquisition analysis).
RT–qPCR. Total RNA was isolated from cells using the RNAeasy Micro kit
(Qiagen), and reverse transcribed using Superscript III Reverse transcriptase
(Invitrogen). RT–qPCR was performed using Power Sybr Green PCR Master Mix
(Applied Biosystems) and the rate of dye incorporation was monitored using the
StepOne Plus RealTime PCR system (Applied Biosystems). Three biological
replicates were used for each condition. Data were analysed by StepOne Plus RT
PCR software v2.1 and Microsoft excel. TBP transcript levels were used for
normalization of each target (¼DCT). RT–qPCR CT values were analysed using
the 2 DDCTð Þ method to calculate the fold expression.
Quantiﬁcation of mtDNA content by qPCR. Total DNA was prepared using
extraction buffer (0.2mgml 1 proteinase K, 0.2% SDS and 5mM EDTA in PBS)
and incubated at 50 C for 3 h. DNA was precipitated with 3M sodium acetate (pH
5.2) and isopropanol for 20min on ice before centrifugation at 8,000g at 4 C. The
DNA pellet was washed and air dried. qPCR ampliﬁcation was performed on
200 pg of total DNA using the StepOne Plus RealTime PCR system (Applied
Biosystems) and Power Sybr Green PCR Master mix (ABI) following the
manufacturer’s instruction. A fragment of mitochondrial COI gene, the established
marker for mtDNA content in mouse cells, was ampliﬁed using the nuclear
encoded Ndufv1 gene as endogenous reference. The level of mtDNA was
calculated using the DCT of average CT of mtDNA and nDNA (DCT¼CT
nDNACT mtDNA) as 2 DCTð Þ.
In vivo perfusion imaging and phosphorus spectroscopy. All in vivo NMR
experiments were performed at 4 T in a 20-cm free bore magnet (Magnex,
Scientiﬁc Ltd) with a Bruker Biospec spectrometer (Bruker Medical Gmbh). Mice
were positioned supine on a water-heating pad to ensure a stable body temperature
at 37 C. Animal anaesthesia was induced with 4% isoﬂurane (Forene, Abbott) and
maintained with 1 1.75% isoﬂurane delivered in 1.5 lmin 1 oxygen ﬂow to keep
a stable respiratory frequency.
Perfusion data were collected with a 1H whole-body 9-cm inner diameter
transmitter volume coil for blood selective (Mþ ) and non-selective (M ) tagging
and a 2-cm diameter 1H surface coil for reception. The tissue blood ﬂow was
measured by a custom-developed STIR sequence (TR¼ 10 s; Tev¼ 1.2 s; NR¼ 60),
and gastrocnemius muscle blood perfusion (f; mlmin 1 per 100 g) was extracted
from perfusion maps as follows:
f ¼ l=Tev ln Mþ Mð Þ= Mþ þMð Þ 1 exp Tev=T1ð Þð Þþ 1f g
For calculations, the blood/tissue partition coefﬁcient l was ﬁxed at 0.9 and muscle
relaxation time T1 at 1.3 s.
Muscle metabolites were probed by a 31P saddle-shaped coil (10mm) placed
around the calf. After localized adjustment of ﬁeld homogeneity on the water
signal, 31P spectra were acquired at a repetition time of 2.5 s (100 ms broad pulse,
spectral width 12 kHz, 4,096 data points, 360 NS (number of scans ). Zero-ﬁlling
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(8 kHz), 8-Hz line broadening exponential multiplication, Fourier transform,
manual phase correction and baseline correction were carried out on the acquired
31P spectra. Peak integrations were performed to calculate phosphorus metabolite
ratios and pH:
pH ¼ 6:75þ log 3:27 dPið Þ= dPi 5:69ð Þ½ 
with dPi the chemical shift between phosphocreatine (PCr) and inorganic
phosphate (Pi).
In vivo force measurements. The grip strength test is a non-invasive method
designed to evaluate mouse muscle force in vivo. A grip meter (Bio-GT3, BIOSEB),
attached to a force transducer, measured the peak force generated. Septic and
MSC-injected (21 days post injury) mice were placed with the four paws on a grid
and gently pulled backward until they released the grip. Five trials were conducted
for hindlimb grip strengths and, before statistical analysis, a mean value was
calculated for each mouse using the tree median data. Results are expressed as the
result of tree peak forces (in g), normalized to the body weight (in g).
Skinned ﬁbre experiments. TA muscles were dissected from septic and
MSC-injected (21 days post injury) mice. Small bundles of two to ﬁve ﬁbres were
manually isolated from the muscles as previously described. Chemical skinning was
carried out using Triton X-100. Skinned ﬁbres were mounted in the Displacement
Measuring System KD 2300 (model 0.5 SU, Kaman Instrumentation, Colorado
Springs, CO, USA) To perform force measurements. Skinned ﬁbre preparations
were incubated for 1 h in relaxing solution (pCa 9.0, low calcium content)
(pCa¼  log10[Ca2þ ]) containing 1% Triton X-100 (v/v) to solubilize the
sarcolemma and the sarcoplasmic reticulum membranes, and were subsequently
washed several times in relaxing solution without detergent. Fibres were adjusted to
slack length and then stretched progressively until the tension developed at pCa 4.5
(activating solution, high calcium content) became maximal. Tension/pCa
relationships were obtained by exposing skinned ﬁbres sequentially to solutions of
decreasing pCa until maximal tension (Tmax) was reached (at pCa 4.5). Isometric
tension was recorded continuously using a chart recorder (model 1200, Linear,
Reno, Nevada, USA). To obtain Ca2þ sensitivity (pCa50) and Hill coefﬁcient values
(nH), data for the relative tension (T/Tmax) were ﬁtted by using a modiﬁed Hill
equation41. The tension obtained at each [Ca2þ ] was normalized to ﬁbre
cross-sectional area. The relaxing (pCa¼ 9.0) and activating (pCa¼ 4.5) solution
compositions were calculated according to Godt and Nosek42. Solutions with
intermediate [Ca2þ ] were obtained by mixing the pCa 9.0 and pCa 4.5 solutions in
appropriate proportions.
Statistical analysis. Statistical analysis was performed using GraphPad Prism
software using appropriate tests (non-parametric Mann–Whitney unless speciﬁed)
and a minimum of 95% conﬁdence interval for signiﬁcance; P-values indicated on
ﬁgures areo0.05 (*),o0.01(**) ando0.001 (***). Figures display average values of
all animals tested±s.d, or ±s.e.m. for RT–qPCR and qPCR, or as speciﬁcally
indicated for the other experiments.
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